Global Conjunctivitis Medication Market to grow at a CAGR of 1.94% during the period 2015 - 2019; Finds New Report

Report forecast the global conjunctivitis medication market to grow at a CAGR of 1.94% during the period 2015-2019.

Conjunctivitis, also called pink eye or Madras eye, is an infection in or inflammation of the conjunctiva. It affects either one or both a person's eyes and can be the result of an allergy, bacteria, or a virus. Allergens such as smoke, pollen, dust mites, eye drops, cosmetics, and perfumes can lead to conjunctivitis. It is usually associated with redness of the eye along with the release of mucoid discharges. Although the condition usually heals without medication, antibiotics are commonly used for treatment to avoid complications due to irritation of the eye.

The report covers the present scenario and the growth prospects of the global conjunctivitis medication market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of various prescription medication along with the over-the-counter (OTC) medication used to treat bacterial, viral, and allergic conjunctivitis.

The market is divided into the following segments based on geography:

• APAC
• EMEA
• Americas

According to the report, increased exposure to harmful pollutants and chemicals is leading to a rise in the number of conjunctivitis cases worldwide. People working in chemical factories and those exposed to automobile exhaust tend to acquire allergic conjunctivitis. The rising awareness of the condition and its treatment options are driving market growth.

Further, the report states that as patents of existing therapies expire, genericization of treatment medication is expected to occur. This will lead to the entry of low-cost generics into the market, reducing overall revenue. In addition, the reluctance of physicians toward the acceptance of new therapies is a challenge to market growth.

Global Conjunctivitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Conjunctivitis Market: Akorn, Alcon, Allergan and Bausch & Lomb

Other Prominent Vendors in the market are: Celsus Therapeutics, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Merck, Nicox, NovaBay, Ocular Therapeutix, Santen Pharmaceutical, Shire (Foresight biotherapeutics), Starpharma, and Sun Pharma.

Market driver

• Increased exposure to chemicals and pollutants
• For a full, detailed list, view our report

Market challenge

• Patent expiry of medication
• For a full, detailed list, view our report

Market trend

• Strategic alliances and M&A
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 72 pages and 40 Exhibit “Global Conjunctivitis Market 2015 - 2019” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market Overview, Market Landscape, Overview: Conjunctivitis, Pipeline analysis, Market segmentation based on condition type, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://mrr.cm/oVg

Find all Healthcare report at : http://www.marketresearchreports.com/healthcare